Treatment is not always warranted for older men with prostate cancer and a short life expectancy, Yale School of Medicine researchers report in the Feb. 27 Archives of Internal Medicine.
- Medicine - Sep 19 Sick, fired and deported: what happens to injured or ill migrant farm workers in Ontario
- Medicine - Sep 19 Ultrasound enhancement provides clarity to damaged tendons, ligaments
- History - Sep 19 Distinguished international scholars of Mexican history gather to discuss past and future
- Social Sciences - Sep 19 National campaign to combat sexual violence complements campus efforts
- Medicine - Sep 19 New Cancer Drug Target Involving Lipid Chemical Messengers
- Medicine - Sep 19 Attend mini medical school
- Environmental Sciences - Sep 19 Letter to the community on the MIT Climate Change Conversation
- Medicine - Sep 19 Neonatal Touch Therapy Pioneer Honored
- Administration - Sep 19 Penn Celebrates National Voter Registration Day
- Pedagogy - Sep 19 U of M to Host Family Fun Day for Kids Who Stutter
- Agronomy - Sep 19 Badger duo experiences an amazing summer on ‘The Amazing Race’
- Microtechnics - Sep 19 Reflected smartphone transmissions enable gesture control
Prostate cancer treatment overused in some older patients
"Treatment can do more harm than good in some instances," said senior author on the study Cary Gross , associate professor of internal medicine at Yale School of Medicine. "Among men who are older and have less aggressive forms of prostate cancer, their cancer is unlikely to progress or cause them harm in their remaining years."
Gross and his team analyzed nine years of Medicare data and found that over the past decade, there has been a trend towards higher use of curative treatment for prostate cancer among men with certain types of tumors and a short life expectancy. The study included 39,270 patients between the ages of 67 and older.
These results suggest that cancer treatment was increasingly aggressive in patients who had the lowest likelihood of seeing clinical benefits, Gross said, noting that while not treating potentially fatal cancer can reflect poor-quality care, aggressively managing disease that is unlikely to progress puts patients at risk for complications and increases costs without medical benefits.
"We found that the percentage of men who received treatment for their prostate cancer treatments increased over time from 61.2% to 67.6% from 1998 through 2007," said Gross, who is a member of Yale Cancer Center. "However, we were surprised to find that the biggest increase was among men with moderate-risk prostate cancer who had the shortest life expectancy. On the other hand, cancer treatment decreased among men with low-risk tumors and longer life expectancy."
Treating patients with shorter life expectancy may add costs or complications without contributing to quality of life, he said. The National Comprehensive Cancer Network practice guidelines in oncology recommend actively monitoring patients as an alternative to medication for patients with less aggressive tumor types and shorter life expectancies.
Gross said that the use of cancer therapies should be guided by clinical evidence and patient preferences. "Future work should explore how better to incorporate both cancer characteristics and patient life expectancy into decision making," said Gross.
Other authors on the study included Ann c. Raldow, M.D., Carolyn J. Presley, M.D., James B. Yu, M.D., Richa Sharma, Pamela R. Soulos, Jessica B. Long, and Danil V. Makarov, M.D.
The National Cancer Institute and the James G. Hirsch Medical Student Research Fellowship funded the study.
Citation: Arch. Inter. Med. Vol. 172, No. 4 (February 27, 2012)
Last job offers
- Arts - 20.9
Assistant or Associate Professor of Product Design
- Computer Science - 20.9
- Agronomy - 20.9
Assistant / Associate Professor in Food Safety Engineering
- Pedagogy - 20.9
Assistant Professor - Educational Technology
- Medicine - 19.9
Family Medicine - Assistant or Associate Professor WOT (AA8186)
- Medicine - 19.9
Anesthesiology and Pain Medicine - Assistant Professor WOT (AA8133)
- Social Sciences - 19.9
Sociology - Assistant Professor (AA8152)
- Social Sciences - 19.9
Sociology - Assistant Professor (AA8151)